《盈喜》邁富時(02556.HK)料中期轉賺最多4,100萬人幣
邁富時(02556.HK)預期,截至2025年6月30日止六個月將扭虧為盈,錄得淨利潤介於約3,180萬元至4,100萬元人民幣(下同),去年同期淨虧損約8.2億元。主要由於集團於2024年5月完成股份在香港聯合交易所上市,因此截至2025年6月30日止六個月上市費用及可轉換可贖回優先股的公允價值變動的影響為零,較去年同期大幅減少;2025年上半年AI市場需求增加,帶動AI+SaaS業務收入持續增長,使毛利增加;及銷售費用、行政費用及研發費用下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.